Stay updated with breaking news from Celltrans Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Cell Therapies for Type I Diabetes (2023 Edition): Global and Country Analysis By Epidemiology, Pipeline and Target Market Assessment"...
The Food and Drug Administration (FDA) quietly allowed a pharmaceutical firm to profit off a life-saving diabetes treatment.
The FDA has recently approved a cellular therapy for type 1 diabetes for the first 1. The therapy, called Lantidra, can reduce the need for insulin injections.
Announced on June 28, 2023, the FDA's approval of donislecel (Lantidra) marks the first approval of an allogeneic pancreatic islet cellular therapy for the treatment of type 1 diabetes.
Australia's retail sales increased more-than-expected in May after remaining flat in the previous month, figures from the Australian Bureau of Statistics showed on Thursday.